ATHERSYS, INC / NEW ATHX Balance Sheet

Athersys, inc / new (ATHX)

Balance Sheet / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Dec'10
Assets
Current assets:
Cash and cash equivalents
32,692	35,041	40,400	44,200	51,000	51,059	47,967	53,353	49,673	29,316	28,234	28,594	31,940	14,753	8,309	13,837	30,414	23,027	28,533	32,346	35,505	26,127	32,368	38,750	44,981	31,948	17,814	18,897	21,345	25,533	7,903	10,857	14,775	8,785	8,539	4,719	2,105
Available-for-sale-securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	11,070	10,187	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	999	3,999	8,003	16,194	13,076
Accounts receivable
-	-	-	-	-	-	573	545	759	586	707	-	1,766	598	298	-	706	361	-	-	-	694	665	715	894	520	453	576	473	490	438	704	399	689	177	426	2,328
Accounts and other receivables
-	-	-	-	-	-	-	-	-	-	-	608	-	-	-	648	-	-	315	2,382	2,837	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid clinical trial costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	92	-	629	-	-	-
Receivable from Angiotech
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	160	175	106
Prepaid clinical trial costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	537	-	-	-	-
Prepaid expenses and other
1,503	1,168	614	849	800	1,791	2,183	2,480	1,020	1,135	1,031	920	1,156	929	855	999	426	429	383	341	386	427	416	310	319	387	283	328	293	286	370	305	256	332	636	341	329
Total current assets
34,471	37,171	42,470	48,074	54,296	57,840	62,635	69,464	58,422	31,190	29,972	30,122	34,862	16,280	20,532	25,671	31,546	23,817	29,231	35,069	38,728	27,248	33,449	39,775	46,194	32,855	18,550	19,801	22,111	26,309	8,711	11,958	16,966	14,434	17,515	21,855	17,944
Equipment, net
3,039	2,882	2,928	3,062	2,882	3,002	3,002	2,578	2,312	2,206	2,265	2,410	2,576	2,605	2,597	2,028	1,253	1,135	1,167	1,207	1,263	1,270	1,331	1,343	1,394	1,333	1,368	1,396	1,310	1,294	1,338	1,349	1,398	1,267	1,318	1,205	955
Deposits and other
1,558	1,613	2,033	2,111	1,737	888	892	866	-	197	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred tax assets
-	-	-	-	-	-	-	-	-	-	198	191	178	-	190	187	184	177	-	-	-	200	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred tax assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	195	203	200	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other
-	-	-	-	-	-	-	-	200	-	-	-	-	175	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	28	28	28	-	-	-	207
Deposits and other
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	28	28	-
Total assets
39,068	41,666	47,431	53,247	58,915	61,730	66,529	72,908	60,934	33,593	32,435	32,723	37,616	19,060	23,319	27,886	32,983	25,129	30,593	36,479	40,191	28,718	34,780	41,118	47,588	34,188	19,918	21,197	23,421	27,603	10,077	13,335	18,392	15,701	18,861	23,088	19,106
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable
-	-	-	10,527	11,454	-	10,084	10,918	8,092	4,469	4,285	4,936	6,618	4,761	3,603	4,170	3,274	2,702	2,639	2,255	2,727	2,767	2,891	2,817	2,454	2,243	1,636	2,818	3,054	1,767	1,309	2,284	2,214	2,301	2,087	1,978	1,498
Accrued compensation and related benefits
872	773	1,003	814	711	1,901	1,366	946	743	1,065	1,017	726	605	1,190	912	712	515	1,024	795	723	546	1,060	909	731	601	1,067	801	577	405	827	669	474	357	444	466	590	580
Accrued clinical trial related costs
1,106	1,160	1,478	2,469	1,567	1,276	1,774	1,674	430	1,453	146	204	267	389	98	234	443	82	179	165	69	126	-	-	-	88	-	-	-	-	-	-	-	-	-	-	-
Accrued clinical trial costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	85	104	96	-	171	286	547	950	598	646	562	872	865	842	207
Accrued expenses and other
859	723	712	869	887	461	273	640	389	425	412	339	407	535	548	629	489	513	475	705	597	664	692	641	890	884	975	824	971	934	979	744	914	663	798	784	1,012
Accrued license fee expense
-	-	-	-	-	-	250	500	1,665	1,900	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
-	-	-	-	-	-	-	-	-	250	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Note payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	190	189	187	185	-	181	179	178	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
-	-	-	-	-	-	-	-	250	-	503	503	503	-	-	-	-	245	10,000	10,000	10,027	75	-	24	46	86	-	51	-	-	759	-	1,789	3,140	2,966	4,178	5,541
Total current liabilities
14,620	12,837	14,853	14,681	17,792	15,475	13,747	14,678	11,569	10,083	6,363	6,708	8,400	6,875	5,161	5,745	4,721	4,756	14,277	14,035	14,151	4,692	4,758	4,496	4,265	4,368	3,583	4,556	4,977	4,478	4,314	4,148	5,836	7,420	7,182	8,372	8,838
Other long-term liabilities
102	220	201	273	351	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Note payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	183	-	-	-	176	174	172	171	169	51	50	-	-	-	-	-
Deferred revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	1,263
Warrant liabilities
-	-	-	-	-	-	-	-	-	-	0	0	-	1,004	2,134	2,369	2,830	649	813	1,068	7,025	2,948	3,204	5,744	13,663	9,823	4,667	4,704	5,272	2,709	3,762	4,634	4,538	983	1,100	1,873	-
Stockholders’ equity:
Preferred stock, at stated value; 10,000,000 shares authorized, and no shares issued and outstanding at March 31, 2020 and December 31, 2019
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Common stock, $0.001 par value; 300,000,000 shares authorized, and 170,770,089 and 159,791,585 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively
171	160	155	152	148	144	140	139	138	122	117	113	111	87	85	85	84	84	83	83	82	78	78	77	77	71	60	57	54	53	30	30	29	24	23	23	19
Additional paid-in capital
459,145	440,735	434,548	428,785	422,638	416,014	411,918	408,091	406,308	373,884	363,485	356,189	353,125	329,373	327,092	324,834	323,540	322,582	321,954	321,330	317,935	307,337	306,706	306,048	305,784	284,323	266,077	260,737	256,030	253,889	232,378	231,482	231,285	226,206	225,228	225,090	214,174
Treasury stock, at cost; 65,732 shares at December 31, 2013
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	279	135	-	-	-	0	-	-	-	-	-	-	-
Accumulated other comprehensive income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	28	36	97	26
Accumulated deficit
-433,300	-417,624	-407,701	-395,686	-385,998	-373,042	-361,721	-351,981	-358,914	-350,630	-337,530	-330,287	-324,020	-318,279	-311,153	-305,147	-298,192	-302,942	-306,534	-300,037	-299,002	-286,520	-279,966	-275,247	-275,922	-264,438	-254,643	-249,029	-243,083	-233,695	-230,458	-227,009	-223,296	-218,960	-214,708	-212,367	-205,214
Total stockholders’ equity
19,008	23,271	27,002	33,251	36,788	43,116	50,337	56,249	47,532	23,376	26,072	26,015	29,216	11,181	16,024	19,772	-	19,724	15,503	21,376	19,015	20,895	26,818	30,878	29,660	19,821	11,494	11,765	13,001	20,247	1,950	4,503	8,018	7,298	10,579	12,843	9,005
Total stockholders' equity
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	25,432	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total liabilities and stockholders’ equity
39,068	41,666	47,431	53,247	58,915	61,730	66,529	72,908	60,934	33,593	32,435	32,723	37,616	19,060	23,319	27,886	32,983	25,129	30,593	36,479	40,191	28,718	34,780	41,118	47,588	34,188	19,918	21,197	23,421	27,603	10,077	13,335	18,392	15,701	18,861	23,088	19,106
Consolidated entity excluding, related party
Accounts receivable
17	17	15	80	11	262	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts payable
10,650	9,048	10,517	-	-	9,163	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Healios
Accounts receivable
259	945	1,105	1,778	1,227	1,108	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Unbilled Contracts Receivable
-	-	290	1,130	1,240	3,620	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts payable
1,068	1,068	792	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deposit from Healios
-	-	0	0	2,000	2,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
65	65	351	2	1,173	674	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Advance from Healios
5,338	5,338	5,375	5,042	3,984	3,139	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock subscription receivable from Healios
7,040	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Healios License Agreement
Accounts receivable
-	-	-	-	-	-	-	-	-	153	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Unbilled Contracts Receivable
-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deposit from Healios
-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Contract with Customer, Liability, Deferred Revenue, Current
-	-	-	-	-	-	-	-	-	521	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Advance from Healios
-	-	-	-	-	-	-	-	-	134	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-